Buchumschlag

Is metabolic syndrome a risk factor in hepatectomy?: A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations

Metabolic syndrome (MetS) is a risk factor in surgery. MetS can progress to metabolic (dysfunction)-associated fatty liver disease (MAFLD), a vast-growing etiology of primary liver tumors which are major indications for liver surgery. The aim of this meta-analysis was to investigate the impact of Me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Murtha-Lemekhova, Anastasia (VerfasserIn) , Fuchs, Juri (VerfasserIn) , Feiler, Svenja (VerfasserIn) , Schulz, Erik R. (VerfasserIn) , Teroerde, Miriam (VerfasserIn) , Kalkum, Eva (VerfasserIn) , Klotz, Rosa (VerfasserIn) , Billeter, Adrian (VerfasserIn) , Probst, Pascal (VerfasserIn) , Hoffmann, Katrin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 January 2022
In: BMC medicine
Year: 2022, Jahrgang: 20, Pages: 1-13
ISSN:1741-7015
DOI:10.1186/s12916-022-02239-x
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12916-022-02239-x
Volltext
Verfasserangaben:Anastasia Murtha-Lemekhova, Juri Fuchs, Svenja Feiler, Erik Schulz, Miriam Teroerde, Eva Kalkum, Rosa Klotz, Adrian Billeter, Pascal Probst and Katrin Hoffmann
Beschreibung
Zusammenfassung:Metabolic syndrome (MetS) is a risk factor in surgery. MetS can progress to metabolic (dysfunction)-associated fatty liver disease (MAFLD), a vast-growing etiology of primary liver tumors which are major indications for liver surgery. The aim of this meta-analysis was to investigate the impact of MetS on complications and long-term outcomes after hepatectomy.
Beschreibung:Gesehen am 09.09.2022
Beschreibung:Online Resource
ISSN:1741-7015
DOI:10.1186/s12916-022-02239-x

Ähnliche Einträge